e-drug
[Top] [All Lists]

[e-drug] Bedaquiline treatment reaches 200 patients in Georgia

E-DRUG: Bedaquiline treatment reaches 200 patients in Georgia
------------------------------------------------------------------------------------
[Many of the countries of the former Soviet Union face the same challenges with 
access to essential medicines as 'developing' countries.  There is a huge 
burden of MDR tuberculosis. Rather than a donation, I believe it could be good 
if the drug could become available as an affordable generic under CL so Georgia 
could retain sustainable sovereignty over the program. BS, Moderator]

Georgia is one of the first countries to benefit from the USAID/Janssen
Therapeutics bedaquiline (BDQ) donation program. Along with delamanid, BDQ
is one of only two new TB medicines released to the market in over 40
years. These medicines are being used for the treatment of MDR-TB patients,
as well as TB patients who have experienced life-altering side effects or
developed intolerance or resistance to some second-line TB drugs. Medicines
donated through the program arrived in the country in the summer of 2015. And,
as of May 31, 2016, there are 200 patients on BDQ. The USAID-funded Systems
for Improved Access to Pharmaceuticals and Services (SIAPS) Program,
implemented by Management Sciences for Health, provided support to Georgia
to offer these medicines to TB patients.

SIAPS has been providing technical assistance in Georgia to implement
active drug safety monitoring (aDSM). This has included acting as
secretariat of the aDSM Working Group, which consists of all stakeholders
in TB control, facilitating coordination meetings, and providing expertise
in aDSM implementation. SIAPS also supports the National Center for TB and
Lung Diseases in developing the capacity of health professionals in ADR
clinical management, recording, and reporting. SIAPS also supports the
NCTBLD in implementing the web-based Pharmacovigilance Monitoring System
(PViMS) developed by SIAPS, which will enable the National TB Program to
monitor the safety and effectiveness of medicines.

Kelly Sawyer, MPH*
Technical Associate, TB *
Systems for Improved Access to Pharmaceuticals and Services (SIAPS)
Management Sciences for Health
4301 North Fairfax Drive
Arlington, VA 22203
United States
E-mail: ksawyer@msh.org 
<Prev in Thread] Current Thread [Next in Thread>
  • [e-drug] Bedaquiline treatment reaches 200 patients in Georgia, Sawyer, Kelly <=